Intelligent Bio SolutionsINBS +0.45%44 Days Inventory is 102.96 as of Mar. 2026, which is 46% below its 10-year median of 190.29. GuruFocus rates INBS with a GF Score™ of 44/100 and a GF Value™ of $3.93 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Intelligent Bio Solutions ranks better than 77.1% on this metric.
The historical rank and industry rank for Intelligent Bio Solutions's Days Inventory or its related term are showing as below:
INBS'
s Days Inventory Range Over the Past 10 Years
Min: 110.75 Med: 190.29 Max: 384.62
Current: 110.75
During the past 9 years, Intelligent Bio Solutions's highest Days Inventory was 384.62. The lowest was 110.75. And the median was 190.29.
INBS's Days Inventory is ranked better than 77.1% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.785
vs INBS: 110.75
Inventory Turnover measures how fast the company turns over its inventory within a year.
Intelligent Bio Solutions's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.89.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Intelligent Bio Solutions's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.56.
Intelligent Bio Solutions (NAS:INBS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Intelligent Bio Solutions's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Intelligent Bio Solutions's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Intelligent Bio Solutions Days Inventory Related Terms
Intelligent Bio Solutions Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INBS vs ITOC, WOK, BMRA: Days Inventory Comparison
For the Medical Devices subindustry, Intelligent Bio Solutions's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligent Bio Solutions Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Days Inventory distribution charts can be found below:
* The bar in red indicates where Intelligent Bio Solutions's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions (INBS) has a Days Inventory of 102.96 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Intelligent Bio Solutions and its competitors. This is 46% below median its historical median of 190.29. Over the past decade, Intelligent Bio Solutions' Days Inventory has ranged from 110.75 to 384.62. According to the industry distribution chart, Intelligent Bio Solutions ranks #180 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 22.9%.
Is Intelligent Bio Solutions' Days Inventory too high?
Intelligent Bio Solutions' current Days Inventory of 102.96 is 46% below median its 10-year median of 190.29. Over the past 10 years, this metric has ranged from a low of 110.75 to a high of 384.62. The Medical Devices & Instruments industry median Days Inventory is 179.79. Intelligent Bio Solutions' value of 102.96 is 42.7% below this industry median. Based on the distribution chart, Intelligent Bio Solutions ranks #180 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Days Inventory compare to ITOC and WOK?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #180 out of 786 companies for Days Inventory. This places Intelligent Bio Solutions in the top 23% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.79. Intelligent Bio Solutions' value of 102.96 is 42.7% below this benchmark. Historically, Intelligent Bio Solutions' own Days Inventory has ranged from 110.75 to 384.62 over the past decade. While the company's 10-year median is 190.29 vs. the industry median of 179.79, Intelligent Bio Solutions has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.79, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Intelligent Bio Solutions's current Days Inventory of 102.96 is 42.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Intelligent Bio Solutions and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intelligent Bio Solutions's current Days Inventory is 102.96, which is 46% below median its own 10-year median of 190.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.93, compared to a current price of $2.24 — trading 43% below its estimated fair value. The current Days Inventory is 102.96, which is 46% below median its 10-year median of 190.29 and 42.7% below the Medical Devices & Instruments industry median of 179.79. Intelligent Bio Solutions' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Days Inventory is 102.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intelligent Bio Solutions (INBS) Overvalued in 2026?
Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued.
The current stock price of $2.24 is trading 43% below its estimated GF Value™ of $3.93.
GuruFocus considers Intelligent Bio Solutions to be Possible Value Trap.
Key valuation signals for INBS:
Days Inventory: 102.96 (46% below median its 10-year median of 190.29)
GF Value™: $3.93 vs. price of $2.24 (43% below fair value)
Industry Position: 42.7% below the Medical Devices & Instruments median (#180 of 786)
No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
44GF Score
Get the complete analysis for INBS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INBS has been successfully added to your 
